Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 648 Lung Neoplasms 276 Ovarian Neoplasms 274 Breast Neoplasms 224 Fallopian Tube Neoplasms 134 Neoplasms 118 Small Cell Lung Carcinoma 115 Triple Negative Breast Neoplasms 111 Squamous Cell Carcinoma of Head and Neck 101 Carcinoma, Ovarian Epithelial 95 Neoplasm Metastasis 70 Head and Neck Neoplasms 66 Endometrial Neoplasms 63 Uterine Cervical Neoplasms 58 Adenocarcinoma of Lung 57 Esophageal Neoplasms 55 Central Nervous System Neoplasms 44 Brain Neoplasms 44 Recurrence 42 Prostatic Neoplasms 40 Lymphoma, Large B-Cell, Diffuse 38 Carcinoma 38 Parkinson Disease 4, Autosomal Dominant Lewy Body 37 Neuroblastoma 37 Urinary Bladder Neoplasms 36 Lymphoma 33 Esophageal Squamous Cell Carcinoma 32 Carcinoma, Squamous Cell 29 Melanoma 27 Colorectal Neoplasms 27

Interventions

vandetanib 1 selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡